Published in Clin Pharmacol Ther on November 09, 1973
Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother (1976) 1.94
Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine. Antimicrob Agents Chemother (2011) 1.37
Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics. Antimicrob Agents Chemother (1975) 1.01
Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother (1985) 0.95
Effects of polyaspartic acid on pharmacokinetics of tobramycin in two strains of rat. Antimicrob Agents Chemother (1994) 0.77
Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study). Clin J Am Soc Nephrol (2012) 0.77
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell (1999) 2.52
Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. CMAJ (1988) 2.36
Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ (1999) 2.26
Radioimmunoassay for measurement of gentamicin in blood. Antimicrob Agents Chemother (1973) 2.08
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase. Drug Metab Dispos (1985) 2.06
Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors. Mol Cell Biol (2001) 2.03
An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol (2000) 1.93
Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med (1990) 1.92
Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci U S A (1997) 1.82
Inter- and intrasubject variation in diazepam free fraction. Clin Pharmacol Ther (1979) 1.76
Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. Life Sci (1984) 1.64
Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice. Proc Natl Acad Sci U S A (1991) 1.63
B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol (1999) 1.58
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia (2006) 1.56
Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. J Biol Chem (1990) 1.48
Kinetics of the homogeneous freezing of water. Phys Chem Chem Phys (2010) 1.47
Comparative pharmacogenetics of sparteine and debrisoquine. Clin Pharmacol Ther (1983) 1.47
Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. Can Med Assoc J (1970) 1.46
Sparteine metabolism in Canadian Caucasians. Clin Pharmacol Ther (1982) 1.46
TNFα from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis. Am J Transplant (2013) 1.46
Glutamine-enriched enteral diet enhances bacterial clearance in protected bacterial peritonitis, regardless of glutamine form. JPEN J Parenter Enteral Nutr (1997) 1.46
Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Drug Metab Dispos (1987) 1.45
Reversibility of catecholamine-induced cardiomyopathy in a woman with pheochromocytoma. CMAJ (1989) 1.45
IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha. Am J Hematol (1994) 1.43
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians. Br J Clin Pharmacol (1985) 1.42
Clinical failure of tibial interference screw fixation after anterior cruciate ligament reconstruction. A report of two cases. Am J Sports Med (1997) 1.40
Drug prescribing for the elderly in Saskatchewan during 1976. Can Med Assoc J (1979) 1.40
Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis. J Trauma (1997) 1.39
Glutamine-enhanced bacterial killing by neutrophils from postoperative patients. Nutrition (1997) 1.39
Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax (2005) 1.33
Binge drinking among undergraduate college students in the United States: implications for other substance use. J Am Coll Health (2001) 1.32
Pneumonia in Indian and Eskimo infants and children. I. A clinical study. Can Med Assoc J (1967) 1.31
In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J Pharmacol Exp Ther (2001) 1.31
Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology (1994) 1.28
The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers. Clin Pharmacol Ther (1988) 1.26
Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax (2009) 1.26
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol (1997) 1.26
The effects of continuing medical education on family doctor performance in office practice: a randomized control study. Med Educ (1988) 1.24
Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease. Leukemia (2006) 1.24
Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J (2005) 1.23
Hypotension after intravenous cimetidine. Lancet (1978) 1.23
The displacing effect of a fatty acid on the binding of diazepam to human serum albumin. Biochem Pharmacol (1975) 1.22
Ranitidine kinetics and dynamics. I. Oral dose studies. Clin Pharmacol Ther (1981) 1.20
Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. Environ Mol Mutagen (2012) 1.19
Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs. Life Sci (1983) 1.19
Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry (1976) 1.19
Metabolism of flurazepam by the small intestine. Clin Pharmacol Ther (1977) 1.19
Metabolism of cocaine in man. Clin Pharmacol Ther (1978) 1.19
Two distinct interleukin-3-mediated signal pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, regulate the survival of murine pro-B lymphocytes. Mol Cell Biol (1999) 1.18
Distribution of serum paraoxon hydrolyzing activities in a Canadian population. Can J Physiol Pharmacol (1981) 1.18
Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer (1989) 1.17
Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians. Clin Pharmacol Ther (1984) 1.16
Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect (2002) 1.15
Deficient metabolism of debrisoquine and sparteine. Clin Pharmacol Ther (1980) 1.14
Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J (2010) 1.14
Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics (1991) 1.14
In vitro metabolism of sparteine by human liver: competitive inhibition by debrisoquine. Can J Physiol Pharmacol (1982) 1.13
Zinc lowers high-density lipoprotein-cholesterol levels. JAMA (1980) 1.12
Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene (1999) 1.11
Popliteal entrapment syndrome. Ann Surg (1977) 1.10
Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A (1996) 1.10
Capabilities of liposomes for topological transformation. Proc Natl Acad Sci U S A (2001) 1.10
Comparative drug elimination capacity in man-glutethimide, amobarbital, antipyrine, and sulfinpyrazone. Clin Pharmacol Ther (1973) 1.09
Muscular synergism--II. A minimum-fatigue criterion for load sharing between synergistic muscles. J Biomech (1984) 1.08
Water sorption and mechanical properties of light-cured proprietary composite tooth restorative materials. Biomaterials (1992) 1.07
Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax (2005) 1.07
Hazards of phenylephrine topical medication in persons taking propranolol. Can Med Assoc J (1979) 1.07
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J Biol Chem (1993) 1.07
Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther (1979) 1.06
Cloning of a phosphatidic acid-preferring phospholipase A1 from bovine testis. J Biol Chem (1998) 1.06
Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens (1997) 1.06
Family studies of mephenytoin hydroxylation deficiency. Am J Hum Genet (1986) 1.05
Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol (1997) 1.05
Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia. Oncogene (2010) 1.05
Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo. Br J Clin Pharmacol (1986) 1.04
Improving physician performance by continuing medical education. Can Med Assoc J (1978) 1.04
Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab Dispos (1995) 1.04
Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci (1977) 1.03
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 1.03
Venlafaxine oxidation in vitro is catalysed by CYP2D6. Br J Clin Pharmacol (1996) 1.03
A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway. Clin Pharmacol Ther (1988) 1.03
Outpatient surgical management of arthrofibrosis after anterior cruciate ligament surgery. Am J Sports Med (1994) 1.02
Adrenergic beta-receptors and non-shivering thermogenesis. Nature (1966) 1.02
Blood pressure in blacks. Twin studies in Barbados. Hypertension (1990) 1.02
Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and Orientals. Can J Physiol Pharmacol (1980) 1.02
Antipyrine metabolism in the rat by three hepatic monooxygenases. Life Sci (1980) 1.02